logo image
search icon
OBP2A Antibody Market

OBP2A Antibody Market Size, Share & Trends Analysis Report, By Type (Polyclonal Antibodies, and Monoclonal Antibodies; By Application-(Enzyme Linked Immunosorbent Assay, Immunohistochemistry, & Western Blot), By Region, Forecasts, 2024-2031

Report ID : 2590 | Published : 2024-07-22 | Pages: 180 | Format: PDF/EXCEL

The OBP2A Antibody Market Size was valued at USD 102.9 Mn in 2023 and is predicted to reach USD 419.0 Mn by 2031 at a 19.5% CAGR during the forecast period for 2024-2031.

OBP2A

An OBP2A antibody is a special kind of antibody that can identify and bind to the OBP2A protein. The OBP2A antibody market is poised for growth due to the favorable conditions created by the global expansion of the biomedical and pharmaceutical industries. Furthermore, as targeted therapies and personalized medicine gain popularity, there is a growing demand for OBP2A antibodies to personalize therapy for individual patients. There has been a marked increase in the investment in R&D efforts by several corporations. The pharmaceutical industry uses antibodies against OBP2A to find new drugs, especially for disorders where the protein is involved. The field of molecular biology and immunology is one of the main drivers of the OBP2A antibody industry.

However, the market expansion is hampered by the accessibility and affordability of OBP2A antibodies, which a lack of knowledge and high costs can hinder. The demand for OBP2A antibodies has been boosted as research efforts have been enhanced with the increased focus on understanding viral processes and immune responses. Supply chain problems, lab closures, and delays in non-COVID research programs have all put a temporary damper on market growth. OBP2A antibodies further propelled market expansion and are in great demand because of developments in antibody production technology, rising biomedical research funding, and expanding diagnostic and personalized medicine applications.

Competitive Landscape

Some of the Major Key Players in the OBP2A Antibody Market are

  • CUSABIO
  • LSBio
  • OriGene Technologies
  • United States Biological
  • Thermo Fisher Scientific
  • Proteintech
  • Creative Diagnostics
  • Novus Biologicals
  • Other Prominent Players

Market Segmentation:

The global OBP2A antibody market is segmented based on type and application. Based on type, the market is divided into polyclonal and monoclonal. By application, it is divided into enzyme-linked immunosorbent assay, immunohistochemistry, western blot, and others.

Based on the Type, the Polyclonal Market Segment is Accounted as a Major Contributor to the OBP2A Antibody Market

The polyclonal segment is expected to hold a major global market share in 2023 because of their low price, strong binding affinity, and capacity to identify various OBP2A protein epitopes. This makes them ideal for a wide range of diagnostic and research uses, such as determining the presence or absence of a protein and how it works. They are also easy to produce in large quantities, which means they can keep up with the rising demand in the field of biological research and diagnostics, which are factors that contribute to the substantial market share of polyclonal in this market.

Immunohistochemistry Segment to Witness Growth at a Rapid Rate

The immunohistochemistry segment in the OBP2A antibody market is growing because it allows for the exact detection and localization of OBP2A antibody expression in tissue samples better to understand the protein’s function in different disorders. This method is essential for research and diagnostic purposes.

In the Region, the North American OBP2A Antibody Market Holds a Significant Revenue Share

The North America region is expected to register the highest market share in revenue in the near future. This is because of the highly developed research infrastructure, substantial investments in biotechnology and healthcare, and the existence of prominent pharmaceuticals. In addition, Asia Pacific is anticipated to expand rapidly in the OBP2A antibody market because of more funding for healthcare and scientific research, a growing biotech infrastructure, and a heightened understanding of the value of cutting-edge diagnostic and research instruments. Moreover, demand for OBP2A antibodies is being driven by the region’s booming pharmaceutical industry and government initiatives

Recent Developments:

  • In May 2024, Merck finalized an agreement to purchase the life science firm Mirus Bio for $600 million (around €550 million). Mirus Bio, with headquarters in Madison, Wisconsin, USA, specializes in creating and selling transfection reagents. These reagents are utilized to insert DNA into cells; one example is the TransIT-VirusGEN from Mirus Bio. These chemicals are crucial when making viral vectors for gene and cell treatments.
  • In April 2024, Proteintech Genomics, a division of Proteintech Group, Inc., introduced the MultiProTM Human Fixed Cell Immune Profiling Antibody Cocktail. This new product is part of their multi-omic solutions for single-cell and spatial analysis. This cocktail contains 53 antibodies, 5 of which are isotype controls, that target proteins both inside and outside cells. Product compatibility with the pre-titrated cocktail has been established using 10x Genomics Chromium Single Cell Gene Expression Flex.

OBP2A Antibody Market Report Scope

Report Attribute

Specifications

Market Size Value In 2023

USD 102.9 Mn

Revenue Forecast In 2031

USD 419.0 Mn

Growth Rate CAGR

CAGR of 19.5% from 2024 to 2031

Quantitative Units

Representation of revenue in US$ Mn and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Forecast Year

2024-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Type, Application

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; Southeast Asia; South Korea

Competitive Landscape

CUSABIO, LSBio, OriGene Technologies, United States Biological, Thermo Fisher Scientific, Proteintech, Creative Diagnostics, Novus Biologicals, and other prominent players.

Customization Scope

Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing And Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global OBP2A Antibody Market Snapshot

Chapter 4. Global OBP2A Antibody Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Type Estimates & Trend Analysis
5.1. by Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type:

5.2.1. Polyclonal Antibodies
5.2.2. Monoclonal Antibodies

Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis
6.1. by Application & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:

6.2.1. Enzyme Linked Immunosorbent Assay (ELISA)
6.2.2. Immunohistochemistry (IHC)
6.2.3. Western Blot

Chapter 7. OBP2A Antibody Market Segmentation 3: Regional Estimates & Trend Analysis

7.1. North America
7.1.1. North America OBP2A Antibody Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
7.1.2. North America OBP2A Antibody Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
7.1.3. North America OBP2A Antibody Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

7.2. Europe
7.2.1. Europe OBP2A Antibody Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
7.2.2. Europe OBP2A Antibody Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
7.2.3. Europe OBP2A Antibody Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

7.3. Asia Pacific
7.3.1. Asia Pacific OBP2A Antibody Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
7.3.2. Asia Pacific OBP2A Antibody Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
7.3.3. Asia Pacific OBP2A Antibody Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

7.4. Latin America
7.4.1. Latin America OBP2A Antibody Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
7.4.2. Latin America OBP2A Antibody Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
7.4.3. Latin America OBP2A Antibody Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

7.5. Middle East & Africa
7.5.1. Middle East & Africa OBP2A Antibody Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
7.5.2. Middle East & Africa OBP2A Antibody Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
7.5.3. Middle East & Africa OBP2A Antibody Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles

8.2.1. CUSABIO (China)
8.2.2. LSBio (U.S.)
8.2.3. OriGene Technologies (U.S.)
8.2.4. United States Biological (U.S.)
8.2.5. Thermo Fisher Scientific (U.S.)
8.2.6. Proteintech (U.S.)
8.2.7. Creative Diagnostics (U.S.)
8.2.8. Novus Biologicals (U.S.)
8.2.9. Other Prominent Players

Segmentation of OBP2A Antibody Market

OBP2A Antibody Market- By Type

  • Polyclonal
  • Monoclonal

OBP2A

OBP2A Antibody Market- By Application

  • Enzyme-Linked Immunosorbent Assay
  • Immunohistochemistry
  • Western Blot
  • Others

OBP2A Antibody Market- By Region

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

 

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

 

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the OBP2A Antibody Market Size?

The OBP2A Antibody Market is expected to grow at a 19.5% CAGR during the forecast period for 2024-2031.

CUSABIO, LSBio, OriGene Technologies, United States Biological, Thermo Fisher Scientific, Proteintech, Creative Diagnostics, Novus Biologicals, and ot

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Pharmaceuticals

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach